Home › Bladder Cancer › Texas › Austin
Bladder Cancer clinical trials in Austin, TX
12 studies for Bladder Cancer are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
RecruitingPhase 2
- Texas Oncology-Austin Central ( Site 0107), Austin
- Urology Austin, PLLC ( Site 0109), Austin
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RecruitingPhase 1/2
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RecruitingPhase 3
- USO-Texas Oncology-Central/South Texas, Austin
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RecruitingPhase 1/2
- Texas Oncology (Balcones) - SCRI, Austin
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
RecruitingPhase 3
- Texas Oncology, Austin
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
RecruitingPhase 1/2
- Urology Austin, PLLC ( Site 0008), Austin
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
RecruitingPhase 2
- Urology Austin, PLLC (Urology America), Austin
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
RecruitingPhase 2
- Urology Austin, LLC, Austin
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RecruitingPhase 1/2
- Urology Austin, Austin
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
RecruitingPhase 2/3
- Local Institution - 0187, Austin
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Recruiting
- Austin Urology Institute, Austin
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecruitingObservational studyHealthy volunteers welcome
- Elligo Health Research, Inc., Austin
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY34 studies
- Nashville, TN31 studies
- Houston, TX31 studies
- Boston, MA27 studies
- Dallas, TX27 studies
- Washington, DC26 studies
- Los Angeles, CA24 studies
- Baltimore, MD24 studies
- St. Louis, MO22 studies
- Edison, NJ22 studies
- Seattle, WA21 studies
- Philadelphia, PA21 studies
Other studies in Austin
- Non-Small Cell Lung Cancer30 studies
- Cancer (all types)21 studies
- Obesity20 studies
- Metastatic Cancer19 studies
- Colorectal Cancer19 studies
- Heart Failure18 studies
- Overweight18 studies
- Breast Cancer18 studies
- Ovarian Cancer17 studies
- Endometrial Cancer16 studies
- Depression15 studies
- Prostate Cancer15 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.